DoctorBD Info DoctorBD Info

Precodil

Prednisolone Acetate ·Opsonin Pharma Ltd.·Ophthalmic Suspension

0 views 0 reviews

Administration

Adult: Instill one drop into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue the therapy before completing the course. 

Paediatric: Safety and effectiveness in pediatric patients have not been established.

Effects

Elevation of intraocular pressure (IOP) with possible development of glaucoma and infrequent optic nerve damage, posterior subcapsular cataract formation and delayed wound healing.  Fungal and viral infections of the cornea are particularly may develop coincidentally with long-term applications of steroid.

A one-time accidental overdose of Prednisolone Ophthalmic Suspension generally will not cause acute problems. Long time overdose may show general side-effects. In accidental overdose sufficient water should be taken to dilute the medication.

Indications

Prednisolone eye drops is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.

Pharmacology

Prednisolone decreases inflammation by inhibition of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability. It suppresses the immune system by reducing the activity and production of the lymphocytes and eosinophils.

Precautions

Shake the bottle well before use. Prolonged use of corticosteroids may result in damage to the optic nerve and defects in vision. If this product is used for longer period of time, intraocular pressure should be routinely monitored.

Therapeutic

Glucocorticoids

Other brands with the same generic

More from Opsonin Pharma Ltd.

Reviews (0)

Helpful experiences from real users.

Sign in with Google

Leave a review (no account needed)

Your rating *
Sign in with Google to skip the form fields.

No reviews yet. Be the first to share your experience.